Blue Cross and Blue Shield of North Carolina Medical Policy Update for October 27 2017:
|Medical Guidelines||Reason for Update|
|Allergy Testing||Added “Maximum Units of Service” to list of Related Policies. Minor revision to When Covered section; removed the following statement from paragraph below item 4b – “Additional testing beyond this number will require individual review for medical necessity.” No change to policy intent.|
|Code Bundling Rules Not Addressed in Claim Check||The following information is added to the section on Status “B” codes: Status B code edits are applied to professional and outpatient facility claims. Notification given 8/25/17 for policy effective date of 10/27/17.|
|Endovascular Procedures for Intracranial Arterial Disease||Reference added.|
|Focal Treatments for Prostate Cancer||Reference added. Minor revisions to Description of Procedure.|
|Infertility, Diagnosis and Treatment||Added codes 89290 and 89291 to Billing/Coding section. Specialty Matched Consultant Advisory Panel review 9/27/2017. No change to policy statement.|
|Intrauterine Ablation or Resection of the Endometrium||Added “congenital uterine anomaly” to list of medical contraindications. Reference added. Specialty Matched Consultant Advisory Panel review 9/27/2017. No change to policy statement.|
|Maximum Units of Service||The following statement added to Guidelines section: For allergy testing, greater than 42 patch tests will be reviewed by individual consideration. Documentation of medical necessity for over 42 tests will be necessary. Specific IgE in vitro testing is limited to 36 allergen specific antibodies. Refer to separate medical policy titled “Allergy Testing.” The following statement added to Billing/Coding section: Editing for maximum units of service is not limited to the specific codes listed in this policy.|
|Myoelectric Prosthetic Components for the Upper Limb||Reference added.|
|Noninvasive Fetal RHD Genotyping Using Cell Free Fetal DNA||Policy Guidelines updated. Reference added. Specialty Matched Consultant Advisory Panel review 9/27/2017. No change to policy statement.|
|Radiofrequency Ablation of Miscellaneous Solid Tumors Excluding Liver Tumors||Reference added. Microwave Tumor Ablation added to Related Policies list. Codes 47380 and 47382 removed from Billing section as they pertain to liver tumors.|
Policy Alerts monitors Commercial and Medicare medical policies for changes. While Payers typically update medical policies annually, there are many reasons why a Payer might review or update a policy. When reviews occur out of cycle, they may go unnoticed. Policy Alerts keeps you informed of upcoming and unexpected coverage changes affecting your product. Quickly understanding the changes Payers make can help you adjust reimbursement strategies impacting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on Payer decisions in real-time. Whenever changes occur, email notifications containing a summary of those changes are delivered to your inbox. Clients can access detailed coverage reports and medical policies on the interactive Dashboard portal. Save time and keep focused on the important Payer medical policy reviews and coverage decisions affecting your product!
Policy Alerts takes a client-focused hands-on approach and works hard to provide our customers with helpful insights and actionable analytics over raw data. We understand what our clients need and we are dedicated to making sure we provide timely, accurate and always up-to-date reports that can be used to implement and support a successful reimbursement strategy.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.